TaiwanJ Pharmaceuticals Co., Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was TWD 22.74 million compared to TWD 15.36 million a year ago. Net loss was TWD 6.05 million compared to TWD 92.47 million a year ago.

Basic loss per share from continuing operations was TWD 0.08 compared to TWD 1.23 a year ago. Diluted loss per share from continuing operations was TWD 0.08 compared to TWD 1.23 a year ago.